Meijssen, S.

plasma atorvastatin control patient treatment postprandial cholesterol fasting fasting plasma tg subject fchl subjects clearance lipoprotein hyperlipidemia ͻ0.001 effect fchl vs ͻ0.05 fraction atorvastatin treatment concentration cabeza change castro fchl patients apob 100 density lipoprotein lipoproteins chylomicron value • trl metabolism table /liter lipid reduction trl fractions postprandial lipemia 0.05 eur j clin controls p value level metab atherosclerosi study endocrinol density hepatic j clin ͻ0.01 thromb bruin tw arterioscler apob 48 erkelen disease october remnant lipase downloaded apolipoprotein curve intralipid december fat-loading test ͻ0.005 erkelens dw lipolytic jansen h plasma tg lipoprotein lipase 16 wk fat-loading 10 mg triglyceride lipemia result 0.01 0.02 0.09